Novartis Ag (NVSEF) Short-term Investments (2014 - 2026)

Novartis Ag has disclosed Short-term Investments across 13 years of filings, most recently posting $100.0 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $100.0 million, down 23.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $100.0 million (down 23.08% YoY), and the FY2025 annual result was $155.0 million, down 92.24% from the prior year.
• Short-term Investments came in at $100.0 million for Q1 2026 at Novartis Ag, down from $155.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $16.1 billion in Q2 2022 to a low of $100.0 million in Q1 2026.
• The 5-year median for Short-term Investments is $290.0 million (2023), against an average of $2.2 billion.
• Across the five-year window, Short-term Investments soared 6650.21% in 2022 and sank 98.21% in 2023, its largest moves.
• Novartis Ag's Short-term Investments stood at $11.4 billion in 2022, then slumped by 90.93% to $1.0 billion in 2023, then surged by 93.04% to $2.0 billion in 2024, then tumbled by 92.24% to $155.0 million in 2025, then slumped by 35.48% to $100.0 million in 2026.
• The last three Short-term Investments figures came in at $100.0 million (Q1 2026), $155.0 million (Q4 2025), and $197.0 million (Q3 2025), per Business Quant data.